A guide to the treatment of depression in women by estrogens

References

• Studd JW. Why are estrogens rarely used for the treatment of depression in women? Gynecol Endocrinol 2007;23:63–4
   PubMed Web of Science ®Google Scholar
• Writing Group for the Women's Health Initiative investigators. Risks and benefits of estrogen plus progestin in healthy post-menopausal women. JAMA 2002;228:321–33
   Google Scholar
• Anderson GL, Limacher M, Assaf AR, . Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701–12
   PubMed Web of Science ®Google Scholar
• Renoux C, Dell'Aniello S, Garbe E, Suissa S. Transdermal and oral hormone replacement therapy and the risk of stroke. BMJ 2010;340:c2519
   PubMed Web of Science ®Google Scholar
• Studd J, Panay N. Hormones and depression in women. Climacteric 2004;7:338–46
   PubMed Web of Science ®Google Scholar
• Watson NR, Studd JWW, Savvas M, Garnett T, Baber RJ. Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone. Lancet 1989;8665:730–2
   Google Scholar
• Smith RNH, Studd JWW, Zamblera D, Holland EFN. A randomised comparison over 8 months of 100 micrograms and 200 micrograms twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome. BrJ Obstet Gynaecol 1995;102:475–84
   PubMedGoogle Scholar
• Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW. Transdermal estrogen for the treatment of severe post-natal depression. Lancet 1996;347:930–3
   PubMed Web of Science ®Google Scholar
• Ahokas A, Kaukoranta J, Wahlbeck K, Alto M. Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17beta-estradiol a preliminary study. J Clin Psychiatry 2001;62:332–6
   PubMed Web of Science ®Google Scholar
• Montgomery JC, Brincat M, Tapp A, . Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet 1987;1:297–9
   PubMed Web of Science ®Google Scholar
• Soares CN, Almeida, Joff H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001;58:529–34
   PubMed Web of Science ®Google Scholar
• Rasgon NL, Alshuler LL, Fairbanks LA, . Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women. J Clin Psychiatry 2002;63(Suppl 7):545–8
   Google Scholar
• Studd J, Panay N. Are oestrogens useful for the treatment of depression in women? Best Pract Res Clinic Obstet Gynaecol 2009;23:63–71
   PubMed Web of Science ®Google Scholar
• Mojtabai R. Increase in antidepressant medication in the US adult population between 1990 and 2003. Psychother Psychosom 2008;77:83–92
   PubMed Web of Science ®Google Scholar
• Smoller JW, Allison M, Cochrane BB, . Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative Study. Arch Intern Med 2009;169:2128–39
   PubMed Web of Science ®Google Scholar
• Morrison MF, Kalian MJ, Ten Have T, Katz I, Tweedy K, Battistini M. Lack of efficacy of oestradiol for depression in postmenopausal women: a randomised controlled trial. Biol Psychiatry 2004;55:406–12
   PubMed Web of Science ®Google Scholar
• Fornaro M, Perugi G. The impact of premenstrual dysphoric disorder among 92 bipolar patients. Eur Psychiatry 2010;8:450–4
   Google Scholar
• Soares CN, Zitek B. Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability? J Psychiatry Neurosci 2008;33:331–43
   PubMed Web of Science ®Google Scholar
• Klaiber EL, Broverman DM, Vogel W, Kobayashi Y. Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiatry 1979;36:550–4
   PubMed Web of Science ®Google Scholar
• Panay N, Studd J. Progestogen intolerance and compliance with hormone replacement therapy in menopausal women. Hum Reprod Update 1997;3:159–71
   PubMed Web of Science ®Google Scholar
• Magos AL, Brewster E, Singh R, O'Dowd T, Brincat M, Studd JWW. The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome. Br J Obstet Gynaecol 1986;93:1290–6
   PubMedGoogle Scholar
• Rapkin AJ. Yaz in the treatment of premenstrual dysphoric disorder. J Reprod Med 2008;53:729–41
   PubMed Web of Science ®Google Scholar
• Yonkers KA, O'Brien PM, Eriksson E. Premenstrual syndrome. Lancet 2008;371:1200–10
   PubMed Web of Science ®Google Scholar
• Studd J. Suppression of ovulation for the treatment of severe premenstrual depression. Menopause Int 2007;13:182–4
   PubMedGoogle Scholar
• Studd J, Magos AL. Hormone pellet implantation for menopause and premenstrual syndrome. Obstet Gynecol Clin North Am 1987;14:224–49
   Google Scholar
• Leather AT, Studd JW, Watson NR, Holland EF The treatment of severe premenstrual syndrome with goserelin with and without ‘add-back’ estrogen therapy: a placebo-controlled study. Gynecol Endocrinol 1999;13:48–55
   PubMed Web of Science ®Google Scholar
• Sundstrom I, Nyberg S, Bixo M, Hammarback S, Backstrom T. Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen. Acta Obstet Gynecol Scand 1999;78:891–9
   PubMed Web of Science ®Google Scholar
• Wyatt KM, Dimmock PW, Ismail KM, Jones PW, O'Brien PM. The effectiveness of GnRH analogue with and without “add-back” therapy in treating premenstrual syndrome: a meta analysis. BJOG 2004;111:585–93
   PubMed Web of Science ®Google Scholar
• O'Brien PMS, Ismail KMK. History of premenstrual disorders. O'Brien PMS, Rapkin A, Schmidt P. The Premenstrual Syndromes: PMS and PMDD. London: Informa Healthcare, 2007:1–8
   Google Scholar
• Leather AT, Studd JWW, Watson NR, Holland EFN. The prevention of bone loss in young women treated with GnRH analogues with ‘add back’ oestrogen therapy. Obstet Gynecol 1993; 81:104–7
   PubMed Web of Science ®Google Scholar
• Di Carlo C, Palomba S, Tommaselli GA, . Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome. Pertil Steril 2001;76:850–2
   PubMedGoogle Scholar
• Elovainio M, Teperi J, Aalto AM. Depressive symptoms as predictors of discontinuation of levonorgestrel releasing intrauterine system. Int J Behav Med 2007;14:70–5
   PubMed Web of Science ®Google Scholar
• Sands R, Studd J. Exogenous androgens in postmenopausal women. Am J Med 1995;98:76–9
   PubMed Web of Science ®Google Scholar
• Davis SR. Androgen treatment in women. Med J Aust 1999; 170:545–9
   PubMed Web of Science ®Google Scholar
• Cronje WH, Vashisht A, Studd JW. Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome. Hum Reprod 2004;19:2152–5
   PubMed Web of Science ®Google Scholar
• Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 2000;157:924–30
   PubMed Web of Science ®Google Scholar
• Moses-Kolko EL, Berga SL, Kalro B, Sit DK, Wisner KL. Transdermal estradiol for postpartum depression: a promising treatment option. Clin Obstet Gynecol 2009;52:516–29
   PubMed Web of Science ®Google Scholar
• Lawrie TA, Hofmeyr GJ, De Jager M, . A double blind randomised placebo controlled study of postnatal norethisterone enanthate: the effect on postnatal depression and hormones. Br] Obstet Gynaecol 1998;105:1082–90
   PubMedGoogle Scholar
• Dennis CL, Ross LE, Herxheimer A. Oestrogens and progestins for preventing and treating postpartum depression. Cochrane Database Syst Rev 2008;(4):CD001690
   Web of Science ®Google Scholar
• Carroll DG, Kelley KW. Use of antidepressants for management of hot flushes. Pharmacotherapy 2009;29:1357–66
   PubMed Web of Science ®Google Scholar
• Dennerstein L, Lehert P, Burger H, . Mood and the menopausal transition. J Nerv Ment Dis 1999;187:685–91
   PubMed Web of Science ®Google Scholar
• Soares CN, Frey BN. Challenges and opportunities to manage depression during the menopausal transition and beyond. Psychiatr Clin North Am 2010;33:295–308
   PubMed Web of Science ®Google Scholar
• Graziottin A, Serafini A. Depression and the menopause: why antidepressants are not enough? Menopause Int 2009;15:76–81
   PubMedGoogle Scholar
• Brincat M, Magos A, Studd JW, . Subcutaneous hormone implants for the control of climacteric symptoms. A prospective study. Lancet 1984;1(8367):16–18
   PubMed Web of Science ®Google Scholar
• Vashisht A, Wadsworth F, Carey A, Carey B, Studd J. A study to look at hormonal absorption of progesterone cream used in conjunction with transdermal estrogen. Gynecol Endocrinol 2005;21:101–5
   PubMed Web of Science ®Google Scholar
• Gath D, Rose N, Bond A, Garrod A, Hodges S. Hysterectomy and psychiatric disorder: are the levels of psychiatric morbidity falling? Psychol Med 1995;25:277–83
   PubMed Web of Science ®Google Scholar
• Panay N, Studd JW. The psychotherapeutic effects of estrogens. Gynecol Endocrinol 1998;12:353–65
   PubMed Web of Science ®Google Scholar
• Fink G, Sumner BE. Oestrogen and mental state. Nature 1996;383:306
   PubMed Web of Science ®Google Scholar
• Khastgir G, Studd J. Patients’ outlook, experience and satisfaction with hysterectomy, bilateral oophorectomy, and subsequent continuation of hormone replacement therapy. Am J Obstet Gynecol 2000;183:1427–33
   PubMed Web of Science ®Google Scholar
• Paterson M, Wade-Evans T, Sturdee DW, Thorn MH, Studd JW. Endometrial disease after treatment with oestrogens and progestogens in the climacteric. Br Med J 1980;280:822–4
   PubMed Web of Science ®Google Scholar